Literature DB >> 3261424

Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans.

J D Lumbroso1, F Guermazi, O Hartmann, S Coornaert, Y Rabarison, J G Leclère, D Couanet, C Bayle, J M Caillaud, J Lemerle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3261424

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  18 in total

1.  Guidelines for radioiodinated MIBG scintigraphy in children.

Authors:  Pierre Olivier; Paula Colarinha; Jure Fettich; Sibylle Fischer; Jörgen Frökier; Francesco Giammarile; Isky Gordon; Klaus Hahn; Levent Kabasakal; Mike Mann; Mercedes Mitjavila; Amy Piepsz; Ute Porn; Rune Sixt; Jeannette van Velzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-26       Impact factor: 9.236

2.  Undeserved bad press for bone scans: reply.

Authors:  K Osmanagaoglu
Journal:  Eur J Nucl Med       Date:  1994-10

3.  Screening for adrenal medullary disease in patients with medullary thyroid carcinoma.

Authors:  F Bonnin; M Schlumberger; P Gardet; F Tenenbaum; J Lumbroso; J Leclere; E Comoy; A Megnigbeto; J P Travagli; C Parmentier
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

Review 4.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

5.  High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT.

Authors:  T Sasajima; H Kinouchi; N Tomura; J Watarai; K Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

6.  Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.

Authors:  S Lastoria; S Maurea; C Caracò; E Vergara; L Maurelli; P Indolfi; F Casale; M T di Tullio; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

7.  A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.

Authors:  K Osmanagaoglu; M Lippens; Y Benoit; E Obrie; K Schelstraete; M Simons
Journal:  Eur J Nucl Med       Date:  1993-12

Review 8.  Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Authors:  K K Matthay; B Shulkin; R Ladenstein; J Michon; F Giammarile; V Lewington; A D J Pearson; S L Cohn
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

9.  Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Authors:  Gregory A Yanik; Marguerite T Parisi; Barry L Shulkin; Arlene Naranjo; Susan G Kreissman; Wendy B London; Judith G Villablanca; John M Maris; Julie R Park; Susan L Cohn; Patrick McGrady; Katherine K Matthay
Journal:  J Nucl Med       Date:  2013-02-25       Impact factor: 10.057

10.  Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.

Authors:  F Giammarile; J Lumbroso; M Ricard; B Aubert; O Hartmann; M Schlumberger; C Parmentier
Journal:  Eur J Nucl Med       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.